deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT03150511

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy, and Improve Functional Outcomes Following Peripheral Nerve Injury

Sponsor: Johns Hopkins University

Conditions Peripheral Nerve Injuries
Interventions Tesamorelin 2 Milligrams (MG)
Updated 15 times since 2017 Last updated: Nov 10, 2025 Started: Jun 1, 2018 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Peripheral Nerve Injuries, this trial is actively recruiting participants. The trial is conducted by Johns Hopkins University and has accumulated 15 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Mar 2019 · 7 months · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Jun 2020 · 12 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshot~Jan 2022 – ~Jan 2023 · 12 months · monthly snapshot~Jan 2023 – ~Sep 2023 · 8 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Dec 2024 · 2 months · monthly snapshot~Dec 2024 – ~Dec 2025 · 12 months · monthly snapshot~Dec 2025 – present · 8 months · monthly snapshot

Change History

15 versions recorded

  1. Dec 2025 — Present [monthly]

    Recruiting PHASE2

  2. Dec 2024 — Dec 2025 [monthly]

    Recruiting PHASE2

  3. Oct 2024 — Dec 2024 [monthly]

    Recruiting PHASE2

  4. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

▶ Show 10 earlier versions

  1. Sep 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

    Status: Active Not Recruiting → Recruiting

  2. Jan 2023 — Sep 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Jan 2022 — Jan 2023 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  5. Jun 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  6. Jun 2019 — Jun 2020 [monthly]

    Recruiting PHASE2

  7. Mar 2019 — Jun 2019 [monthly]

    Recruiting PHASE2

  8. Aug 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Jun 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE2

  10. Jul 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johns Hopkins University
  • United States Department of Defense
Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations